| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0002 | 1 |